Clinical Trial Update: Open Label Extension (OLE) of the TDF2 Study, Botswana [NA]

View source ↗

Summary

Open-label extension update for the TDF2 study conducted in Botswana, completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: HIV Infections | NA | Status: COMPLETED | Results posted: 2022-05-13